Larry Anderson,MD,PhD,FACP
@ldandersonjrMyeloma, Waldenstroms, Amyloidosis, CAR-T and Cellular Therapy Specialist at UT Southwestern Medical Center (tweets are my own)
Similar User
@szusmani
@SagarLonialMD
@DrOlaLandgren
@EagleMyeloma
@Myeloma_Doc
@PLMcCarthyMD
@TomBmt133
@jmikhaelmd
@Transplant_Doc
@End_myeloma
@SLentzsch
@IMFjimMYELOMA
@Amyloid_Planet
@AjayNookaMD
@MorieGertz
🎉 We are proud to recognize our outstanding HemeOnc faculty who have been named on D Magazine's Annual List of Area’s Best Doctors! Congrats to all who made the list! @ldandersonjr @SuzanneColeMD Robert Collins, MD @madanatyazan Namrata Peswani, MD Kevin Courtney, MD
Register now for our 2024 Oncology Year in Review CME event on Dec. 7! This program will provide participants with the latest information available as presented at the 2024 @ASCO meeting, 2024 @myESMO meeting, and major findings from other meetings that took place in 2024 from…
When in Rio! UT Southwestern Myeloma team. Looking for another Myeloma specialist to join the fun! #IMS24 #MMSM
Dara/Len vs Len as maintenance after ASCT in newly Dx myeloma: the AURIGA study (Dara/Len significantly improved MRD-negative conversion rate). #mmsm @PlasmaCellPete @utswcancer @Ccostello7 ashpublications.org/blood/article/…
#Myeloma Paper of the Day: Phase 3 AURIGA study of Dara/Rev vs. Rev maintenance in newly diagnosed MM post-ASCT w/ ≥VGPR/MRD+ & anti-CD38 naïve shows Dara/Rev superior w/ 47% reduction in risk of PD or death though more cytopenias & infections: pubmed.ncbi.nlm.nih.gov/39331724/. #mmsm
#IMS24 so proud to see #dorishansen (one of our fearless consortium leaders!!) reporting what many thought was impossible… An IPTW matched analysis of real-world #MMsm pts who received cilta-cel vs ide-cel. 🧵 part 1 - set up and population, even matched for study & time!!
#IMS24 the US #MMsm immunotherapy consortium is growing and I could not be happier to see it! @SurbhiSidanaMD @DrKrinaPatel @bhemato @PlasmaCellPete @ldandersonjr @BiranNoa @khouri_jack @AimazAfrough - missing @AlGarfall @GKaurMD and many more!
Best meeting of #IMS24! Thanks @SurbhiSidanaMD @DrKrinaPatel #dorishansen for leading this endeavor and so many sub-projects 🙏 Cc @PlasmaCellPete @ldandersonjr @AimazAfrough @BiranNoa and many more!
It was great to see everyone at the immunotherapy consortium meeting today! #IMS2024 A powerhouse team for generating real world data in immunotherapy in myeloma.
Best meeting of #IMS24! Thanks @SurbhiSidanaMD @DrKrinaPatel #dorishansen for leading this endeavor and so many sub-projects 🙏 Cc @PlasmaCellPete @ldandersonjr @AimazAfrough @BiranNoa and many more!
UT Southwestern is proud to be ranked by U.S. News & World Report as the No. 1 hospital in DFW for the eighth straight year, as well as one of the nation’s top 25 centers for cancer care.
UT Southwestern is proud to be named by U.S. News & World Report as the No. 1 hospital in DFW for the eighth straight year, with the most nationally ranked specialties of any hospital in Texas. bit.ly/3y7j4q3
Systemic Light Chain Amyloidosis: Review article nejm.org/doi/full/10.10… @vsanchorawala #mmsm #bmtsm #amyloidosis @NEJM
Out now in Journal of Hematology and Oncology: Impact of Extramedullary Multiple Myeloma on Outcomes with Ide-cel: jhoonline.biomedcentral.com/articles/10.11… @myelomaMD @YiLinMDPhD @DrKrinaPatel @SurbhiSidanaMD #dorishansen @MoffittNews @BioMedCentral Top line results and a brief 🧵 1/
Consensus guidelines and recommendations for the management and response assessment of CAR-T cells in clinical practice for rel/ref MM: a report from the IMWG Immunotherapy Committee #mmsm #bmtsm @TomBmt133 @ldandersonjr @szusmani @TheLancetOncol thelancet.com/journals/lanon…
Just out: International Myeloma Working Group guidelines CAR-T cell treatment in myeloma. For Limited time: Link to Free copy & more in thread! @TheLancetOncol @YiLinMDPhD @TomBmt133 @szusmani @chngwj @End_myeloma @bdermanmd @mvmateos @jmikhaelmd et al thelancet.com/journals/lanon…
Review of Toxicity of CAR T-Cell Therapy for Multiple Myeloma karger.com/aha/article/do… @AimazAfrough @GKaurMD @UTSWMedCenter @utswcancer
And to cap the day- @UTSWMedCenter @UTSWHemeOnc MYELOMA CREW #mmsm
Great #mmsm session to close out day 2 of #iwCART24 @VJHemOnc @DrKrinaPatel @ldandersonjr @sridevirajeeve Dr. Damien Green, Dr. Doris Hansen, Dr. Matt Frigault & Dr. Juan Du who joined from China
#EBMT24 Bored between sessions and feel like the cacophony around carfilzomib dosing in myeloma #MMsm has become molto FORTE? Help us standardize our field's practice! 12 questions, <3 min. 🙏 to physicians from 28 countries who've already responded! redcap.link/carfilzomib
MRD as an official endpoint for accelerated approval ODAC votes 12-0 great work by all congratulations!!
Impact of bridging therapy with Ide-cel for myeloma:U.S. Myeloma Immunotherapy Consortium. @BloodCancerJnl Key takeaway: 'Less is more'; exercise caution with intensified/infusional Cy, if feasible. #myeloma #CAR-T shorturl.at/eqyZ5
United States Trends
- 1. Cowboys 71,2 B posts
- 2. soobin 88,2 B posts
- 3. Clippers 11,8 B posts
- 4. KADOKAWA 32,1 B posts
- 5. Norman Powell 2.018 posts
- 6. Jerry 42,7 B posts
- 7. Texans 53,3 B posts
- 8. Mike McCarthy 3.302 posts
- 9. Cooper Rush 11,9 B posts
- 10. sabrina 111 B posts
- 11. Fultz 1.385 posts
- 12. #EeveeDay N/A
- 13. Lindy 3.722 posts
- 14. Eliza 12,1 B posts
- 15. Dyson Daniels 2.870 posts
- 16. #AskShadow 7.443 posts
- 17. Eevee Evolution N/A
- 18. Joe Mixon 10,7 B posts
- 19. Keon Ellis 1.732 posts
- 20. Herta 43,4 B posts
Who to follow
-
Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰
@szusmani -
Sagar Lonial MD
@SagarLonialMD -
C. Ola Landgren, M.D.
@DrOlaLandgren -
Craig Hofmeister
@EagleMyeloma -
Robert Z. Orlowski
@Myeloma_Doc -
Philip McCarthy
@PLMcCarthyMD -
Tom Martin
@TomBmt133 -
Joseph Mikhael
@jmikhaelmd -
Muzaffar Qazilbash
@Transplant_Doc -
Luciano J Costa
@End_myeloma -
Suzanne Lentzsch, MD, PhD
@SLentzsch -
Jim Omel
@IMFjimMYELOMA -
Dr. Jeffrey Zonder
@Amyloid_Planet -
Ajay Nooka, MD, MPH
@AjayNookaMD -
Morie Gertz
@MorieGertz
Something went wrong.
Something went wrong.